These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 6430037)
1. Effect of sulfonylurea on glucose, insulin and C-peptide responses to a meal stimulus in a patient with type 2 diabetes and liver disease. Ahrén B; Scherstén B Acta Med Scand; 1984; 215(5):487-91. PubMed ID: 6430037 [TBL] [Abstract][Full Text] [Related]
2. Effects of glipizide on various consecutive insulin secretory stimulations in patients with type 2 diabetes. Ahrén B; Lundquist I; Scherstén B Diabetes Res; 1986 Jul; 3(6):293-300. PubMed ID: 3530592 [TBL] [Abstract][Full Text] [Related]
3. Glipizide increases plasma insulin but not C-peptide level after a standardized breakfast in type 2 diabetic patients. Scheen AJ; Lefebvre PJ; Luyckx AS Eur J Clin Pharmacol; 1984; 26(4):471-4. PubMed ID: 6376145 [TBL] [Abstract][Full Text] [Related]
4. Influence of sulfonylureas on the secretion, disposal and effect of insulin. Almér LO; Johansson E; Melander A; Wåhlin-Boll E Eur J Clin Pharmacol; 1982; 22(1):27-32. PubMed ID: 7047169 [TBL] [Abstract][Full Text] [Related]
5. Comparison of pharmacokinetics, metabolic effects and mechanisms of action of glyburide and glipizide during long-term treatment. Groop L; Groop PH; Stenman S; Saloranta C; Tötterman KJ; Fyhrquist F; Melander A Diabetes Care; 1987; 10(6):671-8. PubMed ID: 3123184 [TBL] [Abstract][Full Text] [Related]
6. Glyburide and glipizide in treatment of diabetic patients with secondary failures to tolazamide or chlorpropamide. Lev JD; Zeidler A; Kumar D Diabetes Care; 1987; 10(6):679-82. PubMed ID: 3123183 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and metabolic effects of glibenclamide and glipizide in type 2 diabetics. Groop L; Wåhlin-Boll E; Groop PH; Tötterman KJ; Melander A; Tolppanen EM; Fyhrqvist F Eur J Clin Pharmacol; 1985; 28(6):697-704. PubMed ID: 3933984 [TBL] [Abstract][Full Text] [Related]
8. A prospective trial of risk factors for sulfonylurea-induced hypoglycemia in type 2 diabetes mellitus. Burge MR; Schmitz-Fiorentino K; Fischette C; Qualls CR; Schade DS JAMA; 1998 Jan; 279(2):137-43. PubMed ID: 9440664 [TBL] [Abstract][Full Text] [Related]
10. Effects of sulfonylurea on the secretion and disposition of insulin and C-peptide. Almér LO; Johansson E; Melander A; Wåhlin-Boll E Acta Med Scand Suppl; 1981; 656():11-8. PubMed ID: 7046346 [TBL] [Abstract][Full Text] [Related]
11. A controlled study of the hypoglycemic and insulinopoietic effect of glipizide and glibenclamide in non-diabetic human subjects. Ceretti AP; Losi S; Orsini G; Emanueli A Arzneimittelforschung; 1975 Apr; 25(4):675-6. PubMed ID: 808231 [TBL] [Abstract][Full Text] [Related]
12. Different effects of glyburide and glipizide on insulin secretion and hepatic glucose production in normal and NIDDM subjects. Groop L; Luzi L; Melander A; Groop PH; Ratheiser K; Simonson DC; DeFronzo RA Diabetes; 1987 Nov; 36(11):1320-8. PubMed ID: 3117609 [TBL] [Abstract][Full Text] [Related]
13. Effect of glipizide on insulin secretion and insulin metabolism in obese type II diabetic patients. Bonora E; Pisani F; Micciolo R; Corgnati A; Muggeo M Diabetes Care; 1987; 10(6):687-91. PubMed ID: 3322723 [TBL] [Abstract][Full Text] [Related]
14. Lack of primary effect of sulphonylurea (glipizide) on plasma lipoproteins and insulin action in former type 2 diabetics with attenuated insulin secretion. Sartor G; Ursing D; Nilsson-Ehle P; Wåhlin-Boll E; Melander A Eur J Clin Pharmacol; 1987; 33(3):279-82. PubMed ID: 3319648 [TBL] [Abstract][Full Text] [Related]
15. Comparative effects of glimepiride and glibenclamide on blood glucose, C-peptide and insulin concentrations in the fasting and postprandial state in normal man. Raptis SA; Hatziagelaki E; Dimitriadis G; Draeger KE; Pfeiffer C; Raptis AE Exp Clin Endocrinol Diabetes; 1999; 107(6):350-5. PubMed ID: 10543411 [TBL] [Abstract][Full Text] [Related]
16. Glipizide: experimental study and comparison with other sulfonylureas. Loubatieres-Mariani MM Acta Endocrinol Suppl (Copenh); 1980; 239():26-32. PubMed ID: 6776761 [No Abstract] [Full Text] [Related]
17. Influence of food intake on the absorption and effect of glipizide in diabetics and in healthy subjects. Wåhlin-Boll E; Melander A; Sartor G; Scherstén B Eur J Clin Pharmacol; 1980 Oct; 18(3):279-83. PubMed ID: 7002565 [TBL] [Abstract][Full Text] [Related]
18. Effect of tolbutamide, glyburide and glipizide administered supraspinally on CA3 hippocampal neuronal cell death and hyperglycemia induced by kainic acid in mice. Kim CH; Park SH; Sim YB; Kim SS; Kim SJ; Lim SM; Jung JS; Suh HW Brain Res; 2014 May; 1564():33-40. PubMed ID: 24713348 [TBL] [Abstract][Full Text] [Related]
19. The effect of glimepiride on pancreatic beta-cell function under hyperglycaemic clamp and hyperinsulinaemic, euglycaemic clamp conditions in non-insulin-dependent diabetes mellitus. Clark HE; Matthews DR Horm Metab Res; 1996 Sep; 28(9):445-50. PubMed ID: 8911981 [TBL] [Abstract][Full Text] [Related]
20. Modification of postprandial hyperglycemia with insulin lispro improves glucose control in patients with type 2 diabetes. Feinglos MN; Thacker CH; English J; Bethel MA; Lane JD Diabetes Care; 1997 Oct; 20(10):1539-42. PubMed ID: 9314631 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]